The latest biotech news

News and Trends 5 Jul 2022

Mogrify and Astellas to address sensorineural hearing loss

Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss. Utilizing Mogrify’s direct cellular reprogramming platform, the collaboration will seek to identify novel combinations of transcription factors involved in cell differentiation to generate new cochlear hair […]

July 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

Positive news from trial for drug to treat major depressive disorder

A company working on treatments for people with mental health issues has had positive feedback from the development program of an anti-depressant targeting major depressive disorder (MDD). ANeuroTech has just announced that after a successful pre-Investigational New Drug Application (IND) meeting, the US Food and Drug Administration (FDA) has given positive feedback on its […]

July 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Jul 2022

AstraZeneca adds to its treatments for blood cancer with $100M deal

AstraZeneca announced today (July 5) it has agreed to buy a company working on a cancer cure. The company will hand over $100 million for TeneoTwo, Inc. in an upfront payment that will include its phase 1 clinical-stage CD19/CD3 T-cell engager, TNB-486, that is being evaluated in relapsed and refractory B-cell non-Hodgkin lymphoma. With the […]

July 5, 2022 - 2 minutesmins - By Liza Laws

News and Trends 5 Jul 2022

Brii Bio takes hepatitis B treatment option

Brii Biosciences Limited, based in China and the U.S., has exercised its option to acquire exclusive development and commercialization rights for VIR-3434 in Greater China as part of its broader collaboration with Vir Biotechnology, Inc. VIR-3434, also known as BRII-877, is a broadly neutralizing monoclonal antibody targeting hepatitis B virus (HBV) that is currently in […]

July 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 4 Jul 2022

Nanoparticle can kill cancer cells and aid muscle relaxation

A nanoparticle that is both a nanoheater and a nanothermometer at the same time has been developed by researchers at a Japanese university. The university said this is a significant development that not only aids muscle relaxation, but it can also kill cancer cells. Satoshi Arai and colleagues at Kanazawa University have successfully showed that […]

July 4, 2022 - 3 minutesmins - By Liza Laws

News and Trends 4 Jul 2022

New home for wet lab incubator in bid to help biotech start-ups and promote life sciences

A lab to bring together the hive minds of those addressing the future challenges in healthcare, including biotech start-ups, is set to open at Discovery Park, Kent, U.K. Barclays has selected the location as the home for its latest Eagle Lab, which will open later this year. The labs are a growing national network currently at […]

July 4, 2022 - 3 minutesmins - By Liza Laws

Cleara Biotech closes $2.5M round for senescence treatment

News and Trends 4 Jul 2022

U.S. biotech financing drops 46% in Q1 compared to 2021

Venture financing deal value for U.S.-headquartered biotech companies dipped by 46% in Q1 2022 compared to Q1 2021, according to analysis from GlobalData. The data and analytics company said the decrease was due to venture capital firms becoming more selective in their investments due to the current economic and geopolitical uncertainties. Mariam Shwea, business fundamentals […]

July 4, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Jul 2022

Progress for hearing preservation trial after Australian approval granted

Approval has been granted by the Australian authorities to allow a French company to progress with a clinical trial testing cochlear implants. Montpellier-based Sensorion will start its proof of concept trial of SENS-401, a drug candidate that aims to protect and preserve inner ear tissue from damage. Sensorion is a biotech company specializing in the […]

July 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Companies come together in fight against Dengue Fever

A vaccine to treat dengue fever, the mosquito-borne disease, is the end goal of two companies who have signed an agreement to produce and commercialize a lead candidate in the fight against the disease. Emergex Vaccines Holding Limited, a clinical-stage biotech company, recently announced that it has agreed a collaboration with the Molecular Biology Institute […]

July 1, 2022 - 4 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

License submitted to FDA for drug to help those with large B-cell lymphoma

A biologics license application has been submitted to the US Food and Drug Administration (FDA) for an antibody to treat patients with B-cell lymphoma. Genmab A/S is a biotechnology company that says its core purpose is to improve the lives of people with cancer. Recently it announced its intent to submit the application for subcutaneous […]

July 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

On this week’s podcast, we have three conversations: with Manfred Rüdiger, CEO of Ariceum Therapeutics; Jon Hague, Unilever’s R&D VP for homecare; and Olivier Rolland, executive director at TWB. Ambrosia and Dionymer winners at 2022 TWB Start-Up Day TWB, which sets up industrial biotechnology R&D projects and designer of innovative and sustainable solutions, announces the […]

July 1, 2022

News and Trends 1 Jul 2022

FMC dips into pheromone crop protection with $200M BioPhero acquisition

FMC Corporation, an agricultural sciences company, has announced a definitive agreement to acquire BioPhero ApS, a Danish pheromone research and production company. The acquisition adds biologically produced pheromone insect control technology to FMC’s product portfolio and R&D pipeline. BioPhero has pioneered a yeast fermentation process for manufacturing pheromones at lower costs and with fewer production […]

July 1, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Mogrify and Astellas to address sensorineural hearing loss

Positive news from trial for drug to treat major depressive disorder

AstraZeneca adds to its treatments for blood cancer with $100M deal

Brii Bio takes hepatitis B treatment option

Nanoparticle can kill cancer cells and aid muscle relaxation

New home for wet lab incubator in bid to help biotech start-ups and promote life sciences

U.S. biotech financing drops 46% in Q1 compared to 2021

Progress for hearing preservation trial after Australian approval granted

Companies come together in fight against Dengue Fever

License submitted to FDA for drug to help those with large B-cell lymphoma

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

FMC dips into pheromone crop protection with $200M BioPhero acquisition

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!